The fasting serum insulin level increased significantly in association with the elevated FBG in the model group; however, NPA intake at higher dose significantly decreased the fasting insulin level in Groups IV-V compared with the NAFLD group. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.